Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
BioNTech SE Sponsored ADR (BNTX) had Receiveable Turnover of 0.45 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$122.78M |
|
$-954.34M |
|
$112.78M |
|
$10.00M |
|
$1.23B |
|
$-1.10B |
|
$103.95M |
|
$-998.41M |
|
$-998.41M |
|
$-954.34M |
|
$-954.34M |
|
$-954.34M |
|
$-954.34M |
|
$-1.10B |
|
$-793.90M |
|
253.34M |
|
253.34M |
|
$-3.77 |
|
$-3.77 |
|
| Balance Sheet Financials | |
$17.79B |
|
$1.20B |
|
$5.87B |
|
$23.65B |
|
$2.27B |
|
$301.02M |
|
$739.36M |
|
$3.01B |
|
$20.65B |
|
$18.56B |
|
$20.65B |
|
251.20M |
|
| Cash Flow Statement Financials | |
$-477.29M |
|
$2.97B |
|
$-95.46M |
|
$8.92B |
|
$11.33B |
|
$2.40B |
|
$33.25M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.85 |
|
-- |
|
-- |
|
0.01 |
|
0.02 |
|
8.14% |
|
-897.82% |
|
-897.82% |
|
-- |
|
-813.16% |
|
-777.27% |
|
$-601.00M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.96 |
|
|
Receiveable Turnover |
0.45 |
200.11 |
|
-4.62% |
|
-5.14% |
|
-4.03% |
|
-4.56% |
|
$82.19 |
|
$-2.37 |
|
$-1.88 |
|